Australia's most trusted
source of pharma news
Posted 6 February 2024 PM
Novavax has announced another round of layoffs, as it attempts to stay afloat long enough to gain some market share for its protein-based Covid vaccine.
The company announced it would reduce its total global workforce by about 12 per cent, including full-time employees and contractors. The move comes after slashing its workforce less than a year ago, when it eliminated one in four positions.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.